The Humoral Anti-Islet Immune Response: Immunochemical Studies of Glycoconjugate Antigens
暂无分享,去创建一个
[1] G. Eisenbarth,et al. Binding of Cytoplasmic Islet Cell Antibodies Is Blocked by Human Pancreatic Glycolipid Extracts , 1988, Diabetes.
[2] L. Mattsson,et al. Characterization of the binding epitope of a monoclonal antibody to sulphatide. , 1988, The Biochemical journal.
[3] M. Mihatsch,et al. Factors associated with early remission of type I diabetes in children treated with cyclosporine. , 1988, The New England journal of medicine.
[4] G. King,et al. A monoclonal antibody (3G5)-defined ganglioside antigen is expressed on the cell surface of microvascular pericytes , 1988, The Journal of experimental medicine.
[5] L. Wicker,et al. Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. , 1988, Journal of immunology.
[6] H. Offner,et al. Gangliosides induce selective modulation of CD4 from helper T lymphocytes. , 1987, Journal of immunology.
[7] A. Sher,et al. Vaccination against cutaneous leishmaniasis in a murine model. II. Immunologic properties of protective and nonprotective subfractions of soluble promastigote extract. , 1987, Journal of immunology.
[8] G. Eisenbarth,et al. Expression of Cytoplasmic Islet Cell Antigens by Rat Pancreas , 1987, Diabetes.
[9] T. Tadakuma,et al. Application of liposomes to generation of monoclonal antibody to glycosphingolipid: production of monoclonal antibody to GgOse4Cer. , 1987, Journal of biochemistry.
[10] W. Curatolo. The physical properties of glycolipids. , 1987, Biochimica et biophysica acta.
[11] G. Eisenbarth,et al. Aging in man. Linear increase of a novel T cell subset defined by antiganglioside monoclonal antibody 3G5 , 1987, The Journal of experimental medicine.
[12] M. Malaise,et al. Elevated anti-alpha-galactosyl antibody titres. A marker of progression in autoimmune thyroid disorders and in endocrine ophthalmopathy? , 1987, Acta endocrinologica.
[13] J. Thomas,et al. Cell surface antigens on rat islet tumors. , 1987, Journal of immunology.
[14] C. Basbaum,et al. Identification of erythrocyte Gal alpha 1-3Gal glycosphingolipids with a mouse monoclonal antibody, Gal-13. , 1987, The Journal of biological chemistry.
[15] G. Eisenbarth,et al. Human islet cell antibodies: immunoglobulin class and subclass distribution defined by monoclonal antibodies. , 1987, Diabetes research.
[16] Y. Uchigata,et al. Pancreatic islet cell surface glycoproteins containing Gal beta 1- 4GlcNAc-R identified by a cytotoxic monoclonal autoantibody , 1987, The Journal of experimental medicine.
[17] M. Feldmann,et al. Derivation of ganglioside-specific T cell lines of suppressor or helper phenotype from cerebrospinal fluid of multiple sclerosis patients , 1986, Journal of Neuroimmunology.
[18] M. Naiki,et al. Specificities of human heterophile Hanganutziu and Deicher (HD) antibodies to glycosphingolipids and a glycoprotein. , 1986, Journal of biochemistry.
[19] L. Wicker,et al. Transfer of Autoimmune Diabetes Mellitus with Splenocytes from Nonobese Diabetic (NOD) Mice , 1986, Diabetes.
[20] E. Antman,et al. Amiodarone therapy and autoimmune thyroid disease. Increase in a new monoclonal antibody-defined T cell subset. , 1986, The American journal of medicine.
[21] E. Handman,et al. The glycoconjugate derived from a Leishmania major receptor for macrophages is a suppressogenic, disease‐promoting antigen in murine cutaneous leishmaniasis , 1986, Parasite immunology.
[22] G. Eisenbarth,et al. Islet cell antigens. Initial studies of their biology and function. , 1986, Molecular biology & medicine.
[23] R. Spiro,et al. Studies on the glycoprotein nature of the thyrotropin receptor: interaction with lectins and purification of the bovine protein with the use of Bandeiraea (Griffonia) simplicifolia I affinity chromatography. , 1986, Endocrinology.
[24] C. Heusser,et al. Non-specific binding of mouse IgM antibodies to lipid antigens , 1985, Journal of Neuroimmunology.
[25] H. Lassmann,et al. Serum antibodies against glycosphingolipids in chronic relapsing experimental allergic encephalomyelitis Demonstration by ELISA and relation to serum in vivo demyelinating activity , 1985, Journal of Neuroimmunology.
[26] M. Sela,et al. Effect of carrier on the immunogenic capacity of synthetic cholera vaccine. , 1985, Molecular immunology.
[27] D. Steiner,et al. Control of insulin gene expression in pancreatic beta-cells and in an insulin-producing cell line, RIN-5F cells. I. Effects of glucose and cyclic AMP on the transcription of insulin mRNA. , 1985, The Journal of biological chemistry.
[28] R. Brady,et al. Polyneuropathy with monoclonal gammopathy: glycolipids are frequently antigens for IgM paraproteins. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[29] E. Handman,et al. Immunization with Leishmania receptor for macrophages protects mice against cutaneous leishmaniasis. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[30] D. R. Gamble,et al. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. , 1985, The New England journal of medicine.
[31] G. Eisenbarth,et al. “Cytoplasmic” Islet Cell Antibodies: Evidence That the Target Antigen Is a Sialoglycoconjugate , 1985, Diabetes.
[32] J. Evans,et al. Structure of a glycolipid reacting with monoclonal IgM in neuropathy and with HNK-1. , 1985, Biochemical and biophysical research communications.
[33] J. Goding,et al. The Leishmania receptor for macrophages is a lipid‐containing glycoconjugate. , 1985, The EMBO journal.
[34] D. Marcus,et al. A review of the immunogenic and immuno-modulatory properties of glycosphingolipids. , 1984, Molecular immunology.
[35] C. Greenblatt,et al. An amphipathic sulphated glycoconjugate of Leishmania: characterization with monoclonal antibodies. , 1984, The EMBO journal.
[36] M. Nirenberg,et al. Monoclonal antibody A2B5 reacts with many gangliosides in neuronal tissue. , 1984, Archives of biochemistry and biophysics.
[37] R. Titus,et al. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity. , 1984, Journal of immunology.
[38] R. Spiro,et al. Occurrence of alpha-D-galactosyl residues in the thyroglobulins from several species. Localization in the saccharide chains of the complex carbohydrate units. , 1984, The Journal of biological chemistry.
[39] R. Alejandro,et al. A ganglioside antigen on the rat pancreatic B cell surface identified by monoclonal antibody R2D6. , 1984, The Journal of clinical investigation.
[40] R. Akeson,et al. Characterization of monoclonal antibody 3G5 and utilization of this antibody to immobilize pancreatic islet cell gangliosides in a solid phase radioassay. , 1984, Endocrinology.
[41] D. Marcus,et al. Antibodies to glycosphingolipids in patients with multiple sclerosis and SLE. , 1984, Journal of immunology.
[42] B. Trapp,et al. IgM in a human neuropathy related to paraproteinemia binds to a carbohydrate determinant in the myelin-associated glycoprotein and to a ganglioside. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[43] A. Tavill,et al. Biochemical Aspects of Human Disease , 1983 .
[44] B. Haynes,et al. Monoclonal Antibodies: Probes for the Study of Autoimmunity and Immunodeficiency , 1983 .
[45] A. E. Boyd,et al. Binding of monoclonal antibody A2B5 to gangliosides. , 1983, Biochemical and biophysical research communications.
[46] S. Witkin,et al. Induction of antibody to asialo GM1 by spermatozoa and its occurrence in the sera of homosexual men with the acquired immune deficiency syndrome (AIDS). , 1983, Clinical and experimental immunology.
[47] N. Kasai,et al. The monoclonal antibody A2B5 is specific to ganglioside GQ1c , 1983, Brain Research.
[48] N. Gregson,et al. IgM paraproteins with immunological specificity for a Schwann cell component and peripheral nerve myelin in patients with polyneuropathy , 1983, Journal of the Neurological Sciences.
[49] H. Dreyfus. New Vistas in Glycolipid Research , 1983 .
[50] G. Bottazzo,et al. IgG subclass distribution in organ specific autoantibodies. The relationship to complement fixing ability. , 1983, Clinical and experimental immunology.
[51] A. Davison,et al. Cellular hypersensitivity to gangliosides and myelin basic protein in multiple sclerosis , 1983, Journal of the Neurological Sciences.
[52] G. Eisenbarth,et al. Islet-cell antibodies and beta-cell function in monozygotic triplets and twins initially discordant for Type I diabetes mellitus. , 1983, The New England journal of medicine.
[53] V. Mureşan,et al. Distribution of sialoglycoconjugates on acinar cells of the mammalian pancreas. , 1982, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[54] J. Palmer,et al. Coxsackie B4 infection and islet cell antibodies three years before overt diabetes. , 1982, The Journal of pediatrics.
[55] G. Eisenbarth,et al. Expression of receptors for tetanus toxin and monoclonal antibody A2B5 by pancreatic islet cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[56] B. Haynes,et al. Increased circulating Ia-antigen-bearing T cells in type I diabetes mellitus. , 1982, The New England journal of medicine.
[57] A. Tiengo,et al. FIVE-YEAR FOLLOW-UP OF NON-DIABETES WITH ISLET-CELL ANTIBODIES , 1982, The Lancet.
[58] J. McNally,et al. EVIDENCE FOR A LONG PREDIABETIC PERIOD IN TYPE I (INSULIN-DEPENDENT) DIABETES MELLITUS , 1981, The Lancet.
[59] H. Offner,et al. Multi-sialo brain gangliosides are powerful stimulators of active E-rosetting lymphocytes from multiple sclerosis patients , 1981, Journal of the Neurological Sciences.
[60] H. Hashimoto,et al. Antiglycolipid autoantibody detected in the sera from systemic lupus erythematosus patients. , 1980, The Journal of clinical investigation.
[61] G. Ellison,et al. Anti-ganglioside antibodies in multiple sclerosis , 1980, Journal of the Neurological Sciences.
[62] H. Offner,et al. Stimulation of active E-rosette forming lymphocytes from multiple sclerosis patients by gangliosides and cerebrosides , 1980, Journal of the Neurological Sciences.
[63] L. Svennerholm,et al. A procedure for the quantitative isolation of brain gangliosides. , 1980, Biochimica et biophysica acta.
[64] M. Nirenberg,et al. Monoclonal antibody to a plasma membrane antigen of neurons. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[65] M. Naiki,et al. Antigen of "serum sickness" type of heterophile antibodies in human sera: indentification as gangliosides with N-glycolylneuraminic acid. , 1977, Biochemical and biophysical research communications.
[66] D. McFarlin,et al. Immune response of Lewis rats to peptide C1 (residues 68-88) of guinea pig and rat myelin basic proteins , 1977, The Journal of experimental medicine.
[67] H. E. Hirsch,et al. Serological reactions against glycolipid-sensitised liposomes in multiple sclerosis , 1976, Nature.
[68] K. Kano,et al. Heterophile antibodies in pathologic human sera resembling antibodies stimulated by foreign species sera. , 1976, Clinical and experimental immunology.
[69] E. Barnes,et al. Antibodies to pancreatic islet cells in insulin-dependent diabetics with coexistent autoimmune disease. , 1974, Lancet.
[70] D. Doniach,et al. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. , 1974, Lancet.
[71] Å. Lernmark,et al. The Pancreatic β-Cell Recognition of Insulin Secretagogues: INFLUENCE OF NEURAMINIDASE TREATMENT ON THE RELEASE OF INSULIN AND THE ISLET CONTENT OF INSULIN, SIALIC ACID, AND CYCLIC ADENOSINE 3′:5′-MONOPHOSPHATE , 1974 .
[72] M. Bornstein,et al. Cerebroside Antibody Inhibits Sulfatide Synthesis and Myelination and Demyelinates in Cord Tissue Cultures , 1974, Science.
[73] L. Svennerholm. CHROMATOGRAPHlC SEPARATION OF HUMAN BRAIN GANGLIOSIDES * , 1963, Journal of neurochemistry.
[74] N. Maclaren,et al. Polyclonal nature of islet cell antibodies in insulin-dependent diabetes. , 1988, Autoimmunity.
[75] Y. Uchigata,et al. Pancreatic islet cell surface glycoproteins containing Gal beta 1-4GlcNAc-R identified by a cytotoxic monoclonal autoantibody. , 1987 .
[76] M. Rapport,et al. Present status of the immunology of gangliosides. , 1984, Advances in experimental medicine and biology.
[77] P. Vitti,et al. Chapter 12 – Autoimmune Thyroid Disease Studied with Monoclonal Antibodies to the Thyrotropin Receptor , 1983 .
[78] S. Hakomori. Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. , 1981, Annual review of biochemistry.
[79] D. Marcus,et al. Preparation and properties of antibodies to gangliosides. , 1980, Advances in experimental medicine and biology.
[80] M. Rapport,et al. Antibodies to total brain gangliosides: titer and specificity of antisera. , 1980, Advances in experimental medicine and biology.
[81] M. Naiki,et al. Detection of antibodies to gangliosides in pathologic human sera. Serum-sickness type heterophile antibodies. , 1980, Advances in experimental medicine and biology.
[82] D. Adams. Thyroid-stimulating autoantibodies. , 1980, Vitamins and hormones.